Cardiac imaging for risk stratification in diabetes

Diabetes Care

Volumn 30, Issue 5, 2007, Pages 1295-1304

  Bax, Jeroen J ^a   Inzucchi, Silvio E ^b   Bonow, Robert O ^c   Schuijf, Joanne D ^a   Freeman, Michael R ^d   Barrett, Eugene J ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE COURSE; HUMAN; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; ECHOCARDIOGRAPHY; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT;

EID: 34247619783     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2094     Document Type: Review

References (72)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
2. International Diabetes Federation [Web site]. Available at www.idf.org. Accessed 28 August 2006
3. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D: European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 10:S1-S10, 2003
4. National Cholesterol Education Program/Adult Treatment Panel III: Third report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) [article online], 2002. Available from http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm. Accessed 30 June 2006 (NIH Publ. no. 02-5215, September 2002)
5. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H: Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 (Suppl. 2):S14-S21, 2001
6. Jacoby RM, Nesto RW: Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 20:736-744, 1992
7. Hammoud T, Tanguay JF, Bourassa MG: Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 36:355-365, 2000
8. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida: American Diabetes Association. Diabetes Care 21:1551-1559, 1998
9. Nesto RW, Kowalchuk GJ: The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 59:23C-30C, 1987
10. Wackers FJ: Diabetes and coronary artery disease: the role of stress myocardial perfusion imaging. Cleve Clin J Med 72:21-33, 2005
11. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, Kelion AD, Al Mohammad A, Prvulovich EM, Shaw LJ, Tweddel AC: Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 31:261-291, 2004
12. DePuey EG, Rozanski A: Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 36:952-955, 1995
13. Smanio PE, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA: Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 30:1687-1692, 1997
14. Kang X, Berman DS, Lewin H, Miranda R, Erel J, Friedman JD, Amanullah AM: Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 137:949-957, 1999
15. Bax JJ, Van der Wall EE, De Roos A, Poldermans D: State of the art and future directions. In Clinical Nuclear Cardiology. 3rd ed. Zaret Bl, Beller GA, Eds. Philadelphia, Mosby, 2005, p. 535-555
16. Picano E, Bedetti G, Varga A, Cseh E: The comparable diagnostic accuracies of dobutamine-stress and dipyridamole-stress echocardiographies: a meta-analysis. Coron Artery Dis 11:151-159, 2000
17. Hennessy TG, Codd MB, Kane G, McCarthy C, McCann HA, Sugrue DD: Evaluation of patients with diabetes mellitus for coronary artery disease using dobutamine stress echocardiography. Coron Artery Dis 8:171-174, 1997
18. Elhendy A, Van Domburg RT, Poldermans D, Bax JJ, Nierop PR, Geleijnse ML, Roelandt JR: Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care 21:1797-1802, 1998
19. Elhendy A, O'Leary EL, Xie F, McGrain AC, Anderson JR, Porter TR: Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 44:2185-2191, 2004
20. Jucquois I, Nihoyannopoulos P, D'Hondt AM, Roelants V, Robert A, Melin JA, Glass D, Vanoverschelde JL: Comparison of myocardial contrast echocardiography with NC100100 and (99m)Tc sestamibi SPECT for detection of resting myocardial perfusion abnormalities in patients with previous myocardial infarction. Heart 83:518-524, 2000
21. Schuijf JD, Shaw LJ, Wijns W, Lamb HJ, Poldermans D, de Roos A, van der Wall EE, Bax JJ: Cardiac imaging in coronary artery disease: differing modalities. Heart 91:1110-1117, 2005
22. Elhendy A, Tsutsui JM, O'Leary EL, Xie F, McGrain AC, Porter TR: Noninvasive diagnosis of coronary artery disease in patients with diabetes by dobutamine stress real-time myocardial contrast perfusion imaging. Diabetes Care 28:1662-1667, 2005
23. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Col lCardiol 15:827-832, 1990
24. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL Jr: American College of Cardiology/American Heart Association Expert Consensus Document on electronbeam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 36:326-340, 2000
25. Schurgin S, Rich S, Mazzone T: Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 24:335-338, 2001
26. Manning WJ, Li W, Edelman RR: A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med 328:828-832, 1993
27. Schuijf JD, Bax JJ, Shaw LJ, de Roos A, Lamb HJ, van der Wall EE, Wijns W: Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am Heart J 151:404-411, 2006
28. Bax JJ, Schuijf JD: Which patients should be referred for non-invasive angiography with multi-slice CT? Int J Cardiol 114:1-3, 2007
29. Schuijf JD, Bax JJ, Jukema JW, Lamb HJ, Vliegen HW, Salm LP, de Roos A, van der Wall EE: Noninvasive angiography and assessment of left ventricular function using multislice computed tomography in patients with type 2 diabetes. Diabetes Care 27:2905-2910, 2004
30. Budoff MJ, Achenbach S, Duerinckx A: Clinical utility of computed tomography and magnetic resonance techniques for noninvasive coronary angiography. J Am Coll Cardiol 42:1867-1878, 2003
31. Salm LP, Bax JJ, Jukema JW, Langerak SE, Vliegen HW, Steendijk P, Lamb HJ, de Roos A, van der Wall EE: Hemodynamic evaluation of saphenous vein coronary artery bypass grafts: relative merits of Doppler flow velocity and SPECT perfusion imaging. J Nucl Cardiol 12:545-552, 2005
32. Schuijf JD, Wijns W, Jukema, JW, Atsma DE, Lamb HJ, Stokkel MP, Dibbets-Schneider P, Decramer I, de Bondt P, van der Wall EE, Vanhoenacker PK, Bax JJ: Relationship between non-invasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol 48:2508-2514, 2006
33. Hacker M, Jakobs T, Matthiesen F, Vollmar C, Nikolaou K, Becker C, Knez A, Pfluger T, Reiser M, Hahn K, Tiling R: Comparison of spiral multidetector CT angiography and myocardial perfusion imaging in the noninvasive detection of functionally relevant coronary artery lesions: first clinical experiences. J Nucl Med 46:1294-1300, 2005
34. Hacker M, Jakobs T, Hack N, Nikolaou K, Becker C, von Ziegler F, Knez A, Konig A, Klauss V, Reiser M, Hahn K, Tiling R: Sixty-four slice spiral CT angiography does not predict the functional relevance of coronary artery stenoses in patients with stable angina. Eur J Nucl Med Mol Imaging 34:4-10, 2006
35. Nitenberg A, Valensi P, Sachs P: Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025, 2003
36. Shaw LJ, Iskandrian AE: Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11:171-185, 2004
37. Schinkel AF, Elhendy A, Van Domburg RT, Bax JJ, Valkema R, Roelandt JR, Poldermans D: Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up. Radiology 225:701-706, 2002
38. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, Friedman JD, Zellweger MJ, Berman DS: Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100:1035-1042, 1999
39. Scholte AJ, Bax JJ, Wackers FJ: Screening of asymptomatic patients with type 2 diabetes mellitus for silent coronary artery disease: combined use of stress myocardial perfusion imaging and coronary calcium scoring. J Nucl Cardiol 13:11-18, 2006
40. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Borges-Neto S, Berman DS, Waters DD, Heller GV: Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105:32-40, 2002
41. Wackers FJ, Zaret BL: Detection of myocardial ischemia in patients with diabetes mellitus. Circulation 105:5-7, 2002
42. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, Berman DS: Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 41:1329-1340, 2003
43. Schuijf JD, Poldermans D, Shaw LJ, Jukema JW, Lamb HJ, de Roos A, Wijns W, van der Wall EE, Bax JJ: Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging 33:93-104, 2006
44. Schinkel AF, Bax JJ, Elhendy A, van Domburg RT, Valkema R, Vourvouri E, Bountioukos M, Rizzello V, Biagini E, Agricola E, Krenning EP, Simoons ML, Poldermans D: Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med 117:1-9, 2004
45. Anand DV, Lim E, Lahiri A, Bax JJ: The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects. Eur Heart J 27:905-912, 2006
46. Marwick TH, Case C, Sawada S, Vasey C, Short L, Lauer M: Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 25:1042-1048, 2002
47. Kamalesh M, Matorin R, Sawada S: Prognostic value of a negative stress echocardiographic study in diabetic patients. Am Heart J 143:163-168, 2002
48. Elhendy A, Arruda AM, Mahoney DW, Pellikka PA: Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 37:1551-1557, 2001
49. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ: Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 228:826-833, 2003
50. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD: Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 46:158-165, 2005
51. Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O'Malley PG: Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am CollCardiol 46:807-814, 2005
52. Raggi P, Shaw LJ, Berman DS, Callister TQ: Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 43:1663-1669, 2004
53. Qu W, Le TT, Azen SP, Xiang M, Wong ND, Doherty TM, Detrano RC: Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care 26:905-910, 2003
54. Raggi P, Bellasi A, Ratti C: Ischemia imaging and plaque imaging in diabetes: complementary tools to improve cardiovascular risk management. Diabetes Care 28:2787-2794, 2005
55. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, Leland OS Jr: Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 108:170-175, 1988
56. Anand DV, Lim E, Hopkins D, Corder R, Shaw LJ, Sharp P, Lipkin D, Lahiri A: Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 27:713-721, 2006
57. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27:1954-1961, 2004
58. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A: Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47:65-71, 2006
59. Zellweger MJ, Hachamovitch R, Kang X, Hayes SW, Friedman JD, Germano G, Pfisterer ME, Berman DS: Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 25:543-550, 2004
60. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ: Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress singlephoton emission computed tomography imaging. J Am Coll Cardiol 45:43-49, 2005
61. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR: Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 90:827-832, 2002
62. Bax JJ, Bonow RO, Tschope D, Inzucchi SE, Barrett E: The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 48:754-760, 2006
63. Miller TD, Redberg R, Wackers FJ: Screening asymptomatic diabetic patients for coronary artery disease: why not? J Am Coll Cardiol 48:761-764, 2006
64. Sorajja P, Chareonthaitawee P, Rajagopalan N, Miller TD: Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation 112:I311-I316, 2006
65. Schuijf JD, Pundziute G, Jukema JW, Lamb HJ, van der Hoeven BL, de Roos A, van der Wall EE, Bax JJ: Diagnostic accuracy of 64-slice multislice computed tomography in the noninvasive evaluation of significant coronary artery disease.Am J Cardiol 98:145-148, 2006
66. Felsher J, Meissner MD, Hakki AH, Heo J, Kane-Marsch S, Iskandrian AS: Exercise thallium imaging in patients with diabetes mellitus: prognostic implications. Arch Intern Med 147:313-317, 1987
67. Schinkel AF, Elhendy A, Van Domburg RT, Bax JJ, Vourvouri EC, Sozzi FB, Valkema R, Roelandt JR, Poldermans D: Prognostic value of dobutamine-atropine stress myocardial perfusion imaging in patients with diabetes. Diabetes Care 25: 1637-1643, 2002
68. Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, Shaw LJ, Amanullah AM, Germano G, Hachamovitch R: Adenosine myocardial perfusion singlephoton emission computed tomography in women compared with men: impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 41:1125-1133, 2003
69. Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ: Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 147:890-896, 2004
70. Bigi R, Desideri A, Cortigiani L, Bax JJ, Celegon L, Fiorentini C: Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care 24:1596-1601, 2001
71. Sozzi FB, Elhendy A, Roelandt JR, Van Domburg RT, Schinkel AF, Vourvouri EC, Bax JJ, De Sutter J, Borghetti A, Poldermans D: Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care 26:1074-1078, 2003
72. D'Andrea A, Severino S, Caso P, De Simone L, Liccardo B, Forni A, Pascotto M, Di Salvo G, Scherillo M, Mininni N, Calabro R: Prognostic value of pharmacological stress echocardiography in diabetic patients. Eur J Echocardiogr 4:202-208, 2003